Novo Nordisk India head eyes 2026 weight-loss drug Wegovy launch - Video
|
Overview
Danish drugmaker Novo Nordisk aims to bring its blockbuster weight-loss drug Wegovy to India in 2026, after securing regulatory approvals and ensuring it has enough supply to meet demand, a top company official told Reuters.
The market opportunity for the drug is huge in the world's most populous country, where obesity rates are high especially among women. Illegal copycat versions of Wegovy are already being sold through online sites.
For more details, check out the link given below:
Novo Nordisk Eyes To Bring Blockbuster Weight-Loss Drug Wegovy To India In 2026
Speakers
Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
